Li et al., 2016 - Google Patents
Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery diseaseLi et al., 2016
View HTML- Document ID
- 5779624159063924696
- Author
- Li Q
- Zhang Y
- Ding D
- Yang Y
- Chen Q
- Su D
- Chen X
- Yang W
- Qiu J
- Ling W
- Publication year
- Publication venue
- The Journal of Clinical Endocrinology & Metabolism
External Links
Snippet
Objectives: Epidemiological studies have shown that serum fibroblast growth factor 21 (FGF21) levels were elevated in obesity and its related metabolic disorders. This prospective study assessed whether there was an independent association of serum FGF21 levels with …
- 102000003973 fibroblast growth factor 21 0 title abstract description 176
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease | |
Bao et al. | Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men | |
Tarasov et al. | Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency | |
Sierra-Johnson et al. | Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index | |
Srinath et al. | Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study | |
Cobb et al. | A novel fasting blood test for insulin resistance and prediabetes | |
Rocha et al. | Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors | |
Thvilum et al. | Excess mortality in patients diagnosed with hypothyroidism: a nationwide cohort study of singletons and twins | |
Gómez-Ambrosi et al. | Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes | |
Chien et al. | Plasma uric acid and the risk of type 2 diabetes in a Chinese community | |
Masuda et al. | Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence | |
Myhill et al. | Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea | |
Gao et al. | Serum fibroblast growth factor 21 levels are positively associated with metabolic syndrome in patients with type 2 diabetes | |
Wang et al. | Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi–Provincial Cohort Study | |
Jauhiainen et al. | The association of 9 amino acids with cardiovascular events in Finnish men in a 12-year follow-up study | |
Shah et al. | Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry | |
Santaniemi et al. | Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin | |
Hu et al. | Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension | |
Shah et al. | Exploring the role of vitamin D in type 1 diabetes, rheumatoid arthritis, and Alzheimer disease: new insights from accurate analysis of 10 forms | |
Elkeles et al. | The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study) | |
Nylén et al. | Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics | |
Yahalom et al. | Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular disease | |
Wang et al. | Testosterone, sex hormone-binding globulin and risk of cardiovascular events: a report from the Outcome Reduction with an Initial Glargine Intervention trial | |
Hoenig | Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target | |
Croyal et al. | Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes |